Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) recorded quarterly Prepaid Assets of $22.4 million in Q1 2026, up 547.02% quarter-over-quarter from $3.5 million in Q4 2025, and up 36.09% on a YoY basis from $16.4 million in Q1 2025.
Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Prepaid Assets history runs 10 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 36.09% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (up 36.09% YoY), while the FY2025 annual figure was $3.5 million, down 85.39% from the prior year.
- Prepaid Assets was $22.4 million for Q1 2026 at Crinetics Pharmaceuticals, up from $3.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $28.5 million in Q3 2025 to a low of $287000.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $8.4 million across 5 years, with a median of $1.9 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets plunged 96.22% in 2022, then soared 6008.98% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $1.9 million in 2022, then slumped by 55.6% to $857000.0 in 2023, then soared by 2659.39% to $23.6 million in 2024, then sank by 85.39% to $3.5 million in 2025, then soared by 547.02% to $22.4 million in 2026.
- The last three Prepaid Assets figures came in at $22.4 million (Q1 2026), $3.5 million (Q4 2025), and $28.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Crinetics Pharmaceuticals | 3.75 Bn | 3.75 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.36 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 28.48 Mn |
| Jun 30, 2025 | 20.40 Mn |
| Mar 31, 2025 | 16.43 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 14.92 Mn |
| Jun 30, 2024 | 334,000.00 |
| Mar 31, 2024 | 3.56 Mn |
| Dec 31, 2023 | 857,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 372,000.00 |
| Mar 31, 2023 | 583,000.00 |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 287,000.00 |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 912,000.00 |
| Sep 30, 2021 | 10.65 Mn |
| Jun 30, 2021 | 7.59 Mn |